U.S. Medtech Market Growth: The Numbers Behind the Trends

The U.S. medtech market continues to be a dominant force globally, representing over 45% of the worldwide medtech revenue as of 2025. Despite recent concerns and headlines suggesting uncertainty, a deeper dive into the numbers tells a different story: one of resilience and steady expansion. Thanks to growing surgical procedure volumes and significant investments in innovation, the United States remains at the forefront of medtech development. In this article, we’ll explore the factors driving growth, key statistics, and the market’s long-term outlook for medtech companies.

U.S. Medtech Market Resilience Amidst Challenges

For the past several decades, the United States has remained the largest market for medical devices worldwide. Its dominance in the field is attributed to several factors: a robust ecosystem of research and development, a highly engaged healthcare workforce, and the adoption of cutting-edge technologies like surgical robotics and AI-powered diagnostics. As of 2025, U.S. medtech companies continue to lead the world in creating transformative healthcare innovations.

However, challenges such as trade policies, workforce shortages, and evolving regulatory landscapes have raised questions about the sustainability of this market. Despite these hurdles, the underlying growth trends and continued demand for innovative solutions signal a positive trajectory for U.S. medtech companies.

U.S. Medtech Market Growth by the Numbers

According to LSI’s recently updated Global Surgical Procedure Volumes (SPV) database, U.S. surgical procedure volumes increased by 3.7% from LSI’s 2024 dataset and the most recent release. This rise has resulted in an upward revision of the procedure volumes from an initial estimate of 92.3 million to 95.7 million in 2024. This growth rate has surpassed expectations, showing a 2.3% compound annual growth rate (CAGR) for 2024-2029, up from the previously projected 1.4%.

As we look forward to 2025, it is anticipated that the United States will perform approximately 97.8 million surgical procedures. The 100-million procedure milestone is on the horizon, likely to be surpassed by 2026 or 2027. This increase in volumes speaks to the growing demand for medical interventions, supported by an aging population and a healthcare system that continues to embrace new technologies.

Procedure Volume Insights and Shifts

U.S. medtech’s growth is not just a story of rising numbers; it’s also one of shifting procedure dynamics. Among the most notable trends is the rise of aesthetic, dermatological, and plastic surgeries. 

However, the fastest-growing medtech segments are not just in aesthetics. Other fast-growing categories include:

1. Stereotactic Radiosurgery
2. Neurosurgical Procedures
3. Spine Procedures

Other notable procedures showing outsized growth include:

• Extracranial Radiotherapy (excluding lung/spine): 17.3% CAGR
• Shoulder Replacement: 11.5% CAGR
• Aortic Valve Repair: 10.4% CAGR
• Ischemic Stroke Mechanical Thrombectomy: 10.0% CAGR
• Nephrectomy: 6.0% CAGR

The demand for procedures like these highlights the strong preference for high-value, complex interventions in the U.S. market, creating ample opportunities for medtech companies with innovative solutions.

Forces Driving U.S. Medtech Growth

Several structural tailwinds are contributing to the expansion of U.S. medtech, and they include:

1. Ambulatory Surgical Centers (ASCs): ASCs are increasingly redefining the landscape of surgical care by offering more efficient, lower-cost alternatives to traditional hospital settings. Their rise is closely tied to the adoption of compact, cost-effective medical devices that are tailored for outpatient care.
2. Technology Adoption: U.S. healthcare providers are some of the quickest adopters of medtech innovation. This includes the integration of AI-powered tools, robotic-assisted surgery, and wearable health monitoring devices. These innovations not only improve the quality of care but also align with value-based care models that aim to optimize patient outcomes while controlling costs.
3. Minimally Invasive Solutions: The demand for minimally invasive surgeries, including robotic surgery and catheter-based interventions, has contributed significantly to market growth. These procedures typically offer shorter recovery times, reduced complications, and improved outcomes for patients, further driving their adoption.

A Comparative Look: U.S. Medtech vs. Europe

In the past, many medtech companies found Europe to be an easier market entry point due to a relatively straightforward regulatory process. However, the implementation of the Medical Device Regulation (MDR) has complicated matters, making the United States a more attractive initial market for new technologies.

The U.S. FDA’s approval process, though stringent, offers a clear regulatory pathway to commercial success, often accompanied by strong reimbursement incentives that encourage adoption. In contrast, Europe’s fragmented reimbursement landscape and more complex post-market surveillance requirements can delay the entry of new devices and slow down market uptake.

What Does This Mean for U.S. Medtech?

The growth of U.S. medtech is driven by both clinical needs and structural factors. The aging population, the rising incidence of chronic diseases, and the push for better patient outcomes are the primary drivers. As surgical volumes increase and new technologies continue to be introduced, U.S. medtech companies remain well-positioned to lead the industry globally.

Still, the U.S. market faces challenges that require adaptability, including evolving trade policies, shifts in healthcare workforce dynamics, and growing competition from both domestic players and international companies. Companies must focus on innovation, maintain strong R&D pipelines, and ensure they can navigate complex regulatory landscapes to continue thriving.

Conclusion

The U.S. medtech market remains a cornerstone of the global healthcare ecosystem. With consistent growth in surgical procedure volumes, strong adoption of innovative technologies, and a supportive environment for medtech startups, the United States continues to be a lucrative market for global medtech companies.

As the market matures, ongoing innovation in areas like minimally invasive surgery, AI, and robotics will be key to sustaining growth. U.S. medtech companies must also focus on meeting the increasing demands for cost-effective, high-quality healthcare solutions. Despite the challenges, the outlook remains positive, and with the right strategies, companies can leverage the opportunities offered by this dynamic market.

The future of U.S. medtech is one of continued innovation, collaboration, and growth as the market evolves to meet the needs of a changing healthcare landscape.